Medicinal product name Avamys
Pharmaceutical form Nasal spray, suspension
Strength 27.5 µg/spray 
Information from the MAH on shortages Not notified
Legal status Rx Prescription (Pr.)
 Summary of product characteristics, patient information leaflet and labeling text approved by the European Medicines Agency is available on European Medicines Agency website
ATC code R01AD12 Nasal preparations

Important notice

Additional information regarding the use for persons aged 75+

If used as "NASAL PREPARATIONS"
SubstanceClassComment
Fluticasoni furoasASuitable for older persons.

Medicinal products (1)

Availability of medicinal product Wholesalers Package size, content Primary packaging Maximum admissible pharmacy price (€ incl. VAT) Product No. Labelling
 Not available (according to the information provided by wholesalers) currently no information on availability from any wholesaler N1
(825 µg/30 dose)
Glass bottle    EU/1/07/434/001  Summary of product characteristics, patient information leaflet and labeling text approved by the European Medicines Agency is available on European Medicines Agency website

Registration information

Marketing authorisation No. EU/1/07/434/001
Date of authorisation Jan 11, 2008
Marketing authorisation holder, country GlaxoSmithKline (Ireland) Limited, Ireland